EvoNext Holdings S.A.
ELVAF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.8M
Close$
$0.94
56.2% downside
Current Fair Value
56.2% downsideOvervalued by 56.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $16.80 Million |
|---|---|
| Enterprise Value | $12.59 Million |
| Earnings per Share | $-0.09 |
| Beta | -0.05 |
| Outstanding Shares | 7,211,552 |
Return
| Return on Equity | -33.49% |
|---|---|
| Return on Assets | -31.90% |
| Return on Invested Capital | -29.74% |
Valuation & Multiples
| P/E Ratio | -18.13 |
|---|---|
| PEG | -23.9 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.97 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
February 19, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About EvoNext Holdings S.A.
49 employees
CEO: Gerhard Lobmaier
EvoNext Holdings SA specializes in the discovery, refinement, and distribution of cutting-edge components for the nutrition, health, and well-being industries. The enterprise was co-founded in 2004 by Alexandra Santana Sørensen, Søren V....